Kiaxone S 250mg/125mg Injection
Marketer
Alicanto Drugs Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Kiaxone S 250mg/125mg Injection
Combiflox 250mg/125mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. Administration must be overseen by a qualified medical practitioner. Strict adherence to the prescribed dosage schedule is vital; complete the entire course, even with symptom improvement, as premature cessation may compromise efficacy. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe side effects necessitate immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) require immediate emergency care. Inform your physician of all concurrent medications, including over-the-counter drugs. Pregnant or lactating individuals should seek medical counsel before use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, avoid driving if drowsiness or dizziness occurs. Sufficient rest, a nutritious diet, and ample hydration contribute to faster recovery. Your doctor may order lab tests to monitor the drug's effects.
Uses of Kiaxone S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Kiaxone S 250mg/125mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not advised.
Common Side effects of Kiaxone S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Kiaxone S 250mg/125mg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Kiaxone S 250mg/125mg Injection works:
The injectable formulation Kiaxone S, containing 250mg Ceftriaxone and 125mg Sulbactam, utilizes a dual-drug approach to combat bacterial infections. Ceftriaxone, a broad-spectrum antibiotic, disrupts bacterial cell wall synthesis, a critical process for bacterial viability. The addition of Sulbactam, a beta-lactamase inhibitor, overcomes bacterial resistance mechanisms, thus optimizing Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of Kiaxone S 250mg/125mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The administration of Kiaxone S 250mg/125mg Injection is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; nevertheless, data from human clinical trials are scarce.
Breast feedingCAUTION
The administration of Kiaxone S 250mg/125mg Injection necessitates prudence during lactation. Mothers should discontinue breastfeeding until their treatment concludes and the medication is fully cleared from their system.
DrivingUNSAFE
Administration of Kiaxone S 250mg/125mg Injection can induce drowsiness, visual disturbances, and dizziness. Driving is prohibited while experiencing these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Kiaxone S 250mg/125mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable medication, Kiaxone S 250mg/125mg, requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage alteration for Kiaxone S 250mg/125mg Injection is unnecessary for those with mild or moderately compromised liver function.
What if you forget to take Kiaxone S 250mg/125mg Injection :
Omit a Kiaxone S 250mg/125mg Injection dose? Seek your physician's advice.
Facts to Know About Kiaxone S 250mg/125mg Injection
| Label | Value |
|---|---|
| Addiction potential | None. |
| Medication Category | Drugs to combat infection |
3,018 People bought this recently